Where is ABEC located?

ABEC is headquartered in Bethlehem, United States. It is registered at Bethlehem, Pennsylvania.

How many employees does ABEC have?

As of Jun 30, 2026, the latest employee count at ABEC is 603.

Is ABEC a funded company?

ABEC is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does ABEC rank among its competitors?

ABEC ranks 9th amongst 174 active competitors, of which 8 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Fusion Antibodies, which secured $1.77M in Feb, 2024.

Who are the top competitors of ABEC?

ABEC's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group. Among them, Fusion Antibodies secured the most recent funding round in February, 2024.

ABEC - 2026 Company Profile & Competitors

Company Details

{}

Website: www.abec.com/
Registered Address: Bethlehem, Pennsylvania

Key Metrics

Founded Year

1974

Location

Bethlehem, United States

Stage

Unfunded

Ranked

9^th among 174 active competitors

Employee Count

603 as on Jun 30, 2026

Similar Companies

SSI Strategy & 219 more

View ABEC's full profile

ABEC is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Abec, Inc. CIN: 231988546 , United States, Active		-	385 (As on Dec 31, 2024)	-

ABEC has not raised any funding rounds yet.

ABEC's employee count trend

ABEC has 603 employees as of Jun 26. Here is ABEC's employee count trend over the years:

Uncover ABEC's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ABEC include SSI Strategy, Fusion Antibodies and ProductLife Group. Here is the list of Top 10 competitors of ABEC, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SSI Strategy 2010, Parsippany Troy Hills (United States), Acquired	Strategic partner for biotech companies, from concept to commercialization	-	Amulet Capital Partners, Sterling Investment Partners ... & 3 others	64/100
2nd	Fusion Antibodies 2001, Belfast (United Kingdom), Public	Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization	$2.5M	Viridian Investment Partners, Co-Fund NI & 4 others	56/100
3rd	ProductLife Group 2000, Suresnes (France), Acquired	Regulatory support and pharmacovigilance services for drug development	-	-	51/100
4th	IDDI 1991, Louvain la Neuve (Belgium), Series A	Provider of bio-statistics and e-clinical services	-	SRIW	51/100
5th	Health Decisions 1989, Durham (United States), Acquired	CRO focused on clinical trial services for data management, monitoring and biostatistics	$1.8M	Excelerate Health Ventures, Boston Millennia Partners ... Read more	46/100
6th	August Research 2012, Sofia (Bulgaria), Acquired	Clinical trial services in Central and Eastern Europe.	-	-	45/100
7th	Phastar 2007, London (United Kingdom), Late Stage	Statistical consulting, clinical trial reporting and data management services.	-	Charterhouse Capital Partners	42/100
8th	Alcedis 1992, Giessen (Germany), Acquired	Alcedis offers IT solutions and services for clinical research.	-	-	39/100
9th	ABEC 1974, Bethlehem (United States), Unfunded	Manufacturer of stainless steel and single-use bioprocess solutions. This provider designs, engineers, and manufactures bioprocess equipment and systems for biopharmaceutical production. Services include process engineering, equipment installation and qualification, and ongoing maintenance and support. A focus on customized solutions allows clients to accelerate the design and build of complete bioprocess lines, and deliver customized single-use disposable containers. The company offers support across the entire bioprocess, setting new benchmarks in time to market.	-	-	39/100
10th	Verified Clinical Trials 2009, Garden City (United States), Unfunded	Prevents duplicate research subjects, ensuring clinical trial integrity and data quality	-	-	38/100